k kumar

Events

Browse Events My events

Blog

Browse articles

Market

Latest Products

More

Forum Explore Popular Posts Games Movies Jobs Offers Fundings

Events Market Blog See all

k kumar

@Kkumar

21 Following

107 Followers

121 posts

Female

14 years old

Living in India

created a new article

7 hrs ·Translate

HR+/HER2- Breast Cancer Market Trends and Future Outlook | #healthcare

HR+/HER2- Breast Cancer Market Trends and Future Outlook

The increasing demand for drugs for HR HER2 advanced breast cancer is driving market growth, with a strong emphasis on next-generation endocrine therapies and innovative combination treatments designed to improve patient outcomes and lower recurrence rates.

Like

Comment

created a new article

1 d ·Translate

HR+/HER2- Breast Cancer: The Transformative Potential of Next-Generation Drugs | #healthcare

HR+/HER2- Breast Cancer: The Transformative Potential of Next-Generation Drugs

Continued research and innovation will be critical in shaping the future of breast cancer therapy.

Like

Comment

created a new article

1 d ·Translate

HR+/HER2- Breast Cancer: A Global Overview of Innovations and Market Trends | #health

HR+/HER2- Breast Cancer: A Global Overview of Innovations and Market Trends

Leading companies like Pfizer, Novartis, and Eli Lilly are at the forefront of innovating new therapies to enhance treatment efficacy.

Like

Comment

created a new article

1 d ·Translate

The Role of CFTR Modulators in the Cystic Fibrosis Market | #healthcare

The Role of CFTR Modulators in the Cystic Fibrosis Market

These drugs work by improving the function of the CFTR protein, which enhances lung function and reduces infection frequency. Drugs like Ivacaftor (Kalydeco), Lumacaftor/Ivacaftor (Orkambi), and Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) have significantly improved patients' lives,

Like

Comment

created a new article

1 d ·Translate

The Rising Demand for Tregs in Therapeutics: Market Insights | #healthcare

The Rising Demand for Tregs in Therapeutics: Market Insights

As more clinical trials yield promising results, the approval and commercialization of Treg-based therapies are expected to accelerate, fueling the market’s upward trajectory.

Like

Comment

Load more posts